Bio-Techne
TECH
#1659
Rank
ยฃ8.12 B
Marketcap
ยฃ51.38
Share price
-0.87%
Change (1 day)
-9.46%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Revenue for Bio-Techne (TECH)

Revenue in 2024 (TTM): ยฃ0.93 Billion

According to Bio-Techne's latest financial reports the company's current revenue (TTM ) is ยฃ0.94 Billion. an increase over the revenue in the year 2023 that were of ยฃ0.89 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bio-Techne from 1996 to 2024

Annual revenue

Year Revenue Change
2024 ยฃ0.95 B6.04%
2023 ยฃ0.89 B-2.91%
2022 ยฃ0.92 B21.36%
2021 ยฃ0.76 B30.13%
2020 ยฃ0.58 B3.21%
2019 ยฃ0.56 B5.75%
2018 ยฃ0.53 B21.1%
2017 ยฃ0.44 B3.62%
2016 ยฃ0.42 B36.37%
2015 ยฃ0.31 B19.62%
2014 ยฃ0.26 B31.09%
2013 ยฃ0.20 B3.55%
2012 ยฃ0.19 B-2%
2011 ยฃ0.19 B11.68%
2010 ยฃ0.17 B7.93%
2009 ยฃ0.16 B-10.67%
2008 ยฃ0.18 B52.43%
2007 ยฃ0.12 B11.18%
2006 ยฃ0.10 B-2.52%
2005 ยฃ0.11 B26.59%
2004 ยฃ87.59 M2.13%
2003 ยฃ85.76 M-0.18%
2002 ยฃ85.92 M2.18%
2001 ยฃ84.09 M15.68%
2000 ยฃ72.69 M20.08%
1999 ยฃ60.53 M27.26%
1998 ยฃ47.57 M23.06%
1997 ยฃ38.65 M14.71%
1996 ยฃ33.69 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ33.53 B 3,442.59%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.04 B 115.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ16.33 B 1,625.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ15.85 B 1,574.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.55 B 64.39%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
ยฃ36.24 B 3,729.30%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ23.99 M-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA